Alejandro De La Hoz Gomez, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Patient Rights | 1 | 2017 | 126 | 0.530 |
Why?
|
Encephalitis | 1 | 2018 | 441 | 0.470 |
Why?
|
Hepatitis C | 1 | 2024 | 1594 | 0.450 |
Why?
|
Colombia | 5 | 2022 | 287 | 0.420 |
Why?
|
Hodgkin Disease | 1 | 2018 | 1383 | 0.360 |
Why?
|
Physician's Role | 1 | 2017 | 923 | 0.350 |
Why?
|
Communication | 1 | 2024 | 3904 | 0.340 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2024 | 4054 | 0.330 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3112 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3234 | 0.200 |
Why?
|
Salmonella Infections | 1 | 2023 | 173 | 0.190 |
Why?
|
HIV Infections | 2 | 2024 | 17542 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8736 | 0.170 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5716 | 0.170 |
Why?
|
Lactococcus | 1 | 2019 | 3 | 0.170 |
Why?
|
Substance Abuse, Intravenous | 1 | 2024 | 530 | 0.170 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15925 | 0.160 |
Why?
|
Staphylococcal Skin Infections | 1 | 2019 | 78 | 0.160 |
Why?
|
Soft Tissue Infections | 1 | 2019 | 166 | 0.140 |
Why?
|
Paternalism | 1 | 2017 | 49 | 0.140 |
Why?
|
Hepacivirus | 1 | 2024 | 1342 | 0.140 |
Why?
|
Candida | 1 | 2018 | 171 | 0.140 |
Why?
|
Internship and Residency | 1 | 2017 | 5947 | 0.140 |
Why?
|
Interviews as Topic | 1 | 2024 | 2741 | 0.130 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2019 | 340 | 0.130 |
Why?
|
Bacteremia | 1 | 2023 | 983 | 0.130 |
Why?
|
Candidiasis | 1 | 2018 | 366 | 0.120 |
Why?
|
Endocarditis, Bacterial | 1 | 2019 | 436 | 0.120 |
Why?
|
Dyslipidemias | 1 | 2022 | 872 | 0.120 |
Why?
|
Qualitative Research | 1 | 2024 | 3139 | 0.100 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 705 | 0.100 |
Why?
|
Influenza Vaccines | 1 | 2018 | 780 | 0.090 |
Why?
|
Polymerase Chain Reaction | 1 | 2020 | 6067 | 0.090 |
Why?
|
Informed Consent | 1 | 2017 | 1010 | 0.090 |
Why?
|
Microbial Sensitivity Tests | 3 | 2023 | 1969 | 0.080 |
Why?
|
Disease Outbreaks | 1 | 2018 | 1761 | 0.080 |
Why?
|
Substance-Related Disorders | 1 | 2024 | 4422 | 0.070 |
Why?
|
Adult | 6 | 2024 | 223317 | 0.060 |
Why?
|
Infant, Newborn | 2 | 2023 | 26396 | 0.060 |
Why?
|
Salmonella | 1 | 2023 | 125 | 0.050 |
Why?
|
Infant | 2 | 2023 | 36485 | 0.050 |
Why?
|
Incidence | 1 | 2020 | 21526 | 0.050 |
Why?
|
Middle Aged | 5 | 2024 | 223233 | 0.050 |
Why?
|
Child, Preschool | 2 | 2023 | 42606 | 0.050 |
Why?
|
Humans | 11 | 2024 | 767040 | 0.050 |
Why?
|
Female | 6 | 2024 | 396660 | 0.050 |
Why?
|
Young Adult | 3 | 2020 | 59980 | 0.040 |
Why?
|
United States | 2 | 2024 | 72971 | 0.040 |
Why?
|
Drug Resistance, Multiple, Fungal | 1 | 2018 | 10 | 0.040 |
Why?
|
Gentamicins | 1 | 2019 | 244 | 0.040 |
Why?
|
Ceftriaxone | 1 | 2019 | 175 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2020 | 59548 | 0.040 |
Why?
|
Anti-Bacterial Agents | 3 | 2023 | 7469 | 0.040 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2019 | 505 | 0.040 |
Why?
|
Methylprednisolone | 1 | 2018 | 386 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15645 | 0.030 |
Why?
|
Vancomycin | 1 | 2019 | 504 | 0.030 |
Why?
|
Child | 2 | 2023 | 80771 | 0.030 |
Why?
|
Drug Resistance, Bacterial | 1 | 2023 | 1063 | 0.030 |
Why?
|
Male | 6 | 2024 | 364203 | 0.030 |
Why?
|
Adolescent | 2 | 2020 | 89046 | 0.030 |
Why?
|
Candida albicans | 1 | 2018 | 376 | 0.030 |
Why?
|
Prednisone | 1 | 2018 | 1566 | 0.030 |
Why?
|
Aged | 3 | 2020 | 171319 | 0.030 |
Why?
|
Antifungal Agents | 1 | 2018 | 760 | 0.030 |
Why?
|
Triazoles | 1 | 2018 | 903 | 0.030 |
Why?
|
Infection Control | 1 | 2018 | 984 | 0.020 |
Why?
|
Heart Valve Prosthesis | 1 | 2019 | 1464 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2018 | 2163 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6310 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4780 | 0.020 |
Why?
|
Echocardiography | 1 | 2019 | 5042 | 0.020 |
Why?
|
Vaccination | 1 | 2018 | 3434 | 0.020 |
Why?
|
Prevalence | 1 | 2022 | 15851 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2021 | 4881 | 0.010 |
Why?
|
Risk Factors | 2 | 2022 | 74886 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2023 | 81659 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 22254 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 26325 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16718 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41718 | 0.010 |
Why?
|